VNUS Medical Technologies to Present at the Roth 21st Annual OC Growth Stock Conference
2009年2月10日 - 2:32AM
PRニュース・ワイアー (英語)
SAN JOSE, Calif., Feb. 9 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (NASDAQ:VNUS), a leading provider of medical
devices for the minimally invasive treatment of venous reflux
disease, today announced its plans to present at the Roth 21st
Annual OC Growth Stock Conference, to be held February 16 - 18,
2009, at The Ritz Carlton in Dana Point, California. The management
speaker will be Peter Osborne, Chief Financial Officer and Vice
President of Finance and Administration. VNUS' presentation is
currently scheduled for 9:30 a.m. PT on Tuesday, February 17, and
will be webcast on the corporate website at
http://ir.vnus.com/events.cfm. About VNUS Medical Technologies,
Inc. VNUS is a leading provider of medical devices for the
minimally invasive treatment of venous reflux, a progressive
condition caused by incompetent vein valves in the leg. VNUS sells
the Closure system, which consists of a proprietary radiofrequency
(RF) generator and proprietary disposable endovenous catheters and
devices to treat diseased veins through the application of
temperature-controlled RF energy. For more information, please
visit the corporate website at http://www.vnus.com/. DATASOURCE:
VNUS Medical Technologies, Inc. CONTACT: Peter Osborne, Chief
Financial Officer and Vice President of Finance and Administration
of VNUS Medical Technologies, Inc., +1-408-360-7499, Web site:
http://www.vnus.com/
Copyright
Vnus Medical Technologies (MM) (NASDAQ:VNUS)
過去 株価チャート
から 8 2024 まで 9 2024
Vnus Medical Technologies (MM) (NASDAQ:VNUS)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about Vnus Medical Technologies (MM) (ナスダック市場): 0 recent articles
その他のVnus Medical Technologies (MM)ニュース記事